CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
December 2023—Inflammatix announced that the FDA has granted breakthrough device designation to its TriVerity acute infection and sepsis test system. The system, which is currently under development, includes the TriVerity test and Myrna instrument.
Read More »